Insider trading

Period: 120 months Stock: OLMA + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

109 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

109 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

109 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

109 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
109 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
109 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

109 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
6 Dec 2023
Paradigm Biocapital Advisors LP 10% owner · indirect
Bought
$1.16M 100,000 at 11.60
1.5%
First buy on file
5 Dec 2023
Graham G. Walmsley Director · indirect
Bought 3×
$1.87M 131,870 at 14.19
7.9%
30 Nov 2023
Harmon Cyrus Director
Sold on a plan
$314.25K 25,000 at 12.57
2.6%
Planned (10b5-1)
22 Nov 2023
Bohen Sean PRESIDENT AND CEO
Sold at will
$388.25K 27,932 at 13.90
16.2%
Not planned
22 Nov 2023
Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF.
Sold at will
$127.02K 9,145 at 13.89
2.1%
Not planned
22 Nov 2023
Zojwalla Naseem CHIEF MEDICAL OFFICER
Sold at will
$98.55K 7,095 at 13.89
18.8%
Not planned
22 Nov 2023
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold at will
$92.41K 6,653 at 13.89
1.1%
Not planned
22 Nov 2023
Harmon Cyrus Director
Sold at will
$55.45K 3,989 at 13.90
0.4%
Not planned
21 Nov 2023
Bohen Sean PRESIDENT AND CEO
Sold at will 2×
$435.88K 29,293 at 14.88
14.5%
Not planned
21 Nov 2023
Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF.
Sold at will 2×
$142.63K 9,597 at 14.86
2.2%
Not planned
21 Nov 2023
Zojwalla Naseem CHIEF MEDICAL OFFICER
Sold at will 2×
$110.75K 7,461 at 14.84
16.5%
Not planned
21 Nov 2023
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold at will 2×
$103.82K 6,976 at 14.88
1.2%
Not planned
21 Nov 2023
Harmon Cyrus Director
Sold at will
$62.29K 4,192 at 14.86
0.4%
Not planned
8 Nov 2023
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold on a plan
$3.52K 200 at 17.61
0.0%
Planned (10b5-1)
3 Nov 2023
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold on a plan
$9.47K 541 at 17.51
0.1%
Planned (10b5-1)
2 Nov 2023
Harmon Cyrus Director
Sold on a plan
$78.20K 5,000 at 15.64
0.5%
Planned (10b5-1)
2 Nov 2023
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold on a plan
$51.18K 3,332 at 15.36
0.6%
Planned (10b5-1)
1 Nov 2023
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold on a plan
$100.15K 6,668 at 15.02
1.2%
Planned (10b5-1)
31 Oct 2023
Harmon Cyrus Director
Sold on a plan
$301.25K 25,000 at 12.05
2.6%
Planned (10b5-1)
29 Sep 2023
Harmon Cyrus Director
Sold on a plan
$310.25K 25,000 at 12.41
2.5%
Planned (10b5-1)
19 Sep 2023
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold on a plan
$253.40K 20,000 at 12.67
3.4%
Planned (10b5-1)
12 Sep 2023
Bought 3×
$14.82M 1,505,932 at 9.84
47.3%
+47% of stake
12 Sep 2023
Graham G. Walmsley Director · indirect
Bought
$5.00M 508,130 at 9.84
43.8%
+44% of stake
5 Sep 2023
Harmon Cyrus Director
Sold on a plan
$116.20K 10,000 at 11.62
1.0%
Planned (10b5-1)
31 Aug 2023
Harmon Cyrus Director
Sold on a plan
$140.40K 15,000 at 9.36
1.5%
Planned (10b5-1)
16 Aug 2023
Harmon Cyrus Director
Sold on a plan
$152.10K 15,000 at 10.14
1.4%
Planned (10b5-1)
8 Jun 2023
Harmon Cyrus Director
Sold at will
$63.00K 10,000 at 6.30
1.0%
Not planned
6 Jun 2023
Harmon Cyrus Director
Sold at will
$31.48K 5,000 at 6.30
0.5%
Not planned
5 Jun 2023
Harmon Cyrus Director
Sold at will
$30.23K 5,000 at 6.05
0.5%
Not planned
6 Apr 2023
Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF.
Bought
no price 10,000 shares
2.6%
2 Sep 2022
Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF.
Bought
no price 20,000 shares
5.5%
First buy on file
10 Jun 2022
Bought 2×
$806.90K 200,000 at 4.03
5.4%
10 Mar 2022
Horn Kinney CHIEF BUSINESS OFFICER
Sold, plan not stated
$24.95K 5,253 at 4.75
68.1%
Sold half or more
10 Jan 2022
Horn Kinney CHIEF BUSINESS OFFICER
Sold, plan not stated
$35.97K 5,251 at 6.85
68.1%
Sold half or more
10 Dec 2021
Myles David C. CHIEF DEVELOPMENT OFFICER
Sold, plan not stated
$103.00K 10,000 at 10.30
1.7%
10 Dec 2021
Horn Kinney CHIEF BUSINESS OFFICER
Sold, plan not stated
$54.56K 5,251 at 10.39
68.1%
Sold half or more
30 Nov 2021
Bought 3×
$6.95M 739,675 at 9.39
24.5%
+25% of stake
29 Nov 2021
Harmon Cyrus CHIEF TECHNOLOGY OFFICER
Sold, plan not stated
$9.90K 400 at 24.76
0.0%
10 Nov 2021
Horn Kinney CHIEF BUSINESS OFFICER
Sold, plan not stated
$743.72K 27,668 at 26.88
93.9%
Sold half or more
19 Oct 2021
Harmon Cyrus CHIEF TECHNOLOGY OFFICER
Sold, plan not stated 2×
$335.79K 12,000 at 27.98
1.1%
14 Oct 2021
Bohen Sean PRESIDENT AND CEO
Sold, plan not stated 2×
$152.36K 5,000 at 30.47
8.7%
11 Oct 2021
Horn Kinney CHIEF BUSINESS OFFICER
Sold, plan not stated 2×
$146.51K 5,251 at 27.90
74.6%
Sold half or more
27 Sep 2021
Bohen Sean PRESIDENT AND CEO
Sold, plan not stated
$32.63K 1,085 at 30.07
2.0%
20 Sep 2021
Harmon Cyrus CHIEF TECHNOLOGY OFFICER
Sold, plan not stated
$315.60K 12,000 at 26.30
1.1%
10 Sep 2021
Horn Kinney CHIEF BUSINESS OFFICER
Sold, plan not stated
$154.27K 5,251 at 29.38
74.6%
Sold half or more
8 Sep 2021
Bohen Sean PRESIDENT AND CEO
Sold, plan not stated
$78.93K 2,631 at 30.00
4.8%
7 Sep 2021
Bohen Sean PRESIDENT AND CEO
Sold, plan not stated
$12.42K 413 at 30.08
0.8%
1 Sep 2021
Bohen Sean PRESIDENT AND CEO
Sold, plan not stated
$26.17K 871 at 30.05
1.6%
19 Aug 2021
Harmon Cyrus CHIEF TECHNOLOGY OFFICER
Sold, plan not stated
$299.64K 12,000 at 24.97
1.1%
10 Aug 2021
Horn Kinney CHIEF BUSINESS OFFICER
Sold, plan not stated 2×
$134.98K 5,251 at 25.71
74.6%
Sold half or more
Showing 51–100 of 109. ← Newer Page 2 of 3 Older →